Company Filing History:
Years Active: 2022
Title: Innovations by Rachel Reboulet
Introduction
Rachel Reboulet is an accomplished inventor based in Chicago, IL. She has made significant contributions to the field of electrokinetic devices and methods, particularly in the context of air quality and respiratory health. Her innovative approach has led to the development of a unique patent that addresses the detection of airborne mold.
Latest Patents
Rachel holds a patent for the invention titled "(1→3)-β-d-glucan as a measure of active mold." This invention describes electrokinetic devices and methods designed to collect assayable agents from a dielectric fluid medium. The technology utilizes plasma generation at high voltage electrodes to induce electrokinetic flow, facilitating the transport of charged particles in an electric voltage gradient. The invention specifically targets the carbohydrate cell wall component (1→3)-β-D-Glucan, which is released into the air by actively growing mold. This airborne fraction is crucial for assessing respiratory health, and the invention selectively tests for a free form that is soluble in aqueous medium. The preferred method for sample collection is through electrokinetic propulsion, although other air sampling methods such as filtration, impactor, or impingement may also be applicable.
Career Highlights
Rachel Reboulet is currently associated with Inspirotec, Inc., where she continues to innovate and develop technologies aimed at improving air quality. Her work has garnered attention for its potential impact on public health, particularly in environments where mold exposure is a concern.
Collaborations
Rachel collaborates with Julian D Gordon, contributing to the advancement of technologies that address environmental health issues. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Rachel Reboulet's contributions to the field of electrokinetic devices highlight her commitment to improving respiratory health through innovative technology. Her patent serves as a testament to her ingenuity and dedication to addressing critical health concerns.